Dr Carol Prince, MD in Detroit, MI - Medicare Dermatology

Dr Carol Prince, MD is a medicare enrolled "Dermatology" physician in Detroit, Michigan. She went to Michigan State University College Of Human Medicine and graduated in 1975 and has 49 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice The St Thomas East End Medical Center Corporation and her current practice location is 1610 West Seven Mile Rd., Detroit, Michigan. You can reach out to her office (for appointments etc.) via phone at (313) 595-3391.

Dr Carol Prince is licensed to practice in Wisconsin (license number 53005) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1922206580.

Contact Information

	Dr Carol Prince, MD
	1610 West Seven Mile Rd., Detroit, MI 48203
	(313) 595-3391
	Not Available

Physician's Profile

Full Name	Dr Carol Prince
Gender	Female
Speciality	Dermatology
Experience	49 Years
Location	1610 West Seven Mile Rd., Detroit, Michigan
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Carol Prince attended and graduated from Michigan State University College Of Human Medicine in 1975

NPI Data:

NPI Number: 1922206580
Provider Enumeration Date: 07/05/2007
Last Update Date: 03/05/2013

Medicare PECOS Information:

PECOS PAC ID: 2961419197
Enrollment ID: I20060314000260

Medical Identifiers

Medical identifiers for Dr Carol Prince such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922206580	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	262140 (New York)	Secondary
207N00000X	Dermatology	53005 (Wisconsin)	Primary
207N00000X	Dermatology	4301038363 (Michigan)	Secondary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
The St Thomas East End Medical Center Corporation	1153366398	9

News Archive

In order to end AIDS, reduce stigma of marginalized groups and accelerate HIV cure research

"'Getting to Zero' has been the slogan for World AIDS Day (Dec. 1) since 2011 and will remain so through until 2015, coinciding with the Millennium Development Goal target of halting and beginning to reverse the spread of HIV/AIDS," Francoise Barre-Sinoussi, director of the Regulation of Retroviral Infections Unit at the Institut Pasteur in Paris, and Adeeba Kamarulzaman, director of the Center of Excellence for Research in AIDS and dean of the Faculty of Medicine at University of Malaya in Kuala Lumpur, write in a New York Times opinion piece.

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy.

More frequent HIV testing would be cost-effective for high- and low-risk groups, researchers report

Early HIV treatment can save lives as well as have profound prevention benefits. But those infected with the virus first must be identified before they can be helped.

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer

A study demonstrating the cost savings realized through the use of the ChemoFx® Drug Response Marker for assisting selection of treatment in recurrent ovarian cancer was published recently in the American Journal of Obstetrics and Gynecology (AJOG).

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Carol Prince allows following entities to bill medicare on her behalf.

Entity Name	Heidelberg Dermatology Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1124045075 PECOS PAC ID: 7719980036 Enrollment ID: O20060807000023

News Archive

In order to end AIDS, reduce stigma of marginalized groups and accelerate HIV cure research

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

More frequent HIV testing would be cost-effective for high- and low-risk groups, researchers report

Early HIV treatment can save lives as well as have profound prevention benefits. But those infected with the virus first must be identified before they can be helped.

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer

Study implicates protein as a trigger of advanced prostate cancer recurrence

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Carol Prince is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Carol Prince, MD 1610 West Seven Mile Rd., Detroit, MI 48203 Ph: (313) 595-3391	Dr Carol Prince, MD 1610 West Seven Mile Rd., Detroit, MI 48203 Ph: (313) 595-3391

News Archive

In order to end AIDS, reduce stigma of marginalized groups and accelerate HIV cure research

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

More frequent HIV testing would be cost-effective for high- and low-risk groups, researchers report

Early HIV treatment can save lives as well as have profound prevention benefits. But those infected with the virus first must be identified before they can be helped.

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer

Study implicates protein as a trigger of advanced prostate cancer recurrence

Dermatology Doctors in Detroit, MI

Dr. Laurie Linden Kohen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2171
James A Brown, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 22151 Moross, Suite 234, Detroit, MI 48236 Phone: 313-885-5110 Fax: 313-885-8755
David M. Ozog, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2454
Dr. Emily L. Keimig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171
Dr. Alison Tisack Boucher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2151
Marsha L. Chaffins, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 3031 West Grand Blvd., Detroit, MI 48202 Phone: 313-916-2454
Dr. Snehal R Desai, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171

Dr Carol Prince, MD - Medicare Dermatology in Detroit, MI

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

In order to end AIDS, reduce stigma of marginalized groups and accelerate HIV cure research

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

More frequent HIV testing would be cost-effective for high- and low-risk groups, researchers report

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer

Study implicates protein as a trigger of advanced prostate cancer recurrence

Medicare Reassignments

In order to end AIDS, reduce stigma of marginalized groups and accelerate HIV cure research

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

More frequent HIV testing would be cost-effective for high- and low-risk groups, researchers report

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer

Study implicates protein as a trigger of advanced prostate cancer recurrence

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

In order to end AIDS, reduce stigma of marginalized groups and accelerate HIV cure research

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

More frequent HIV testing would be cost-effective for high- and low-risk groups, researchers report

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer

Study implicates protein as a trigger of advanced prostate cancer recurrence

Dermatology Doctors in Detroit, MI